Evaluation of bronchoalveolar lavage fluid phospholipids and cytokine release by alveolar macrophages as prognostic markers in sarcoidosis

Respiration

Volumn 70, Issue 4, 2003, Pages 376-381

  Tahanovich, A D ^a   Katovich, I L ^a   Baradzina, H L ^b  

^a BELARUSIAN STATE MEDICAL UNIVERSITY   (Belarus)

^b Institute of Pulmonology and Tuberculosis   (Belarus)

Author keywords

Bronchoalveolar lavage; Cytokines; Macrophages; Phospholipids; Prognosis; Sarcoidosis

Indexed keywords

CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; PHOSPHOLIPID; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CELL SECRETION; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE COURSE; DISEASE MARKER; FEMALE; HUMAN; HUMAN CELL; LUNG ALVEOLUS MACROPHAGE; LUNG LAVAGE; LUNG SARCOIDOSIS; LYMPHOCYTE; LYMPHOCYTOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS;

ADULT; BIOLOGICAL MARKERS; BRONCHOALVEOLAR LAVAGE FLUID; CYTOKINES; FEMALE; HUMANS; INTERLEUKIN-6; MACROPHAGES, ALVEOLAR; MALE; MIDDLE AGED; PHOSPHOLIPIDS; PROGNOSIS; SARCOIDOSIS, PULMONARY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0141649528     PISSN: 00257931     EISSN: None     Source Type: Journal    
DOI: 10.1159/000072901     Document Type: Article

References (14)

1. Newman LS, Rose CS, Maier LA: Medical progress: Sarcoidosis. N Engl J Med 1997;336:1224-1234.
2. Moller DR: Cells and cytokines involved in the pathogenesis of sarcoidosis. Sarcoidosis Vasc Diff Lung Dis 1999;16:24-31.
3. Takizawa H, Satoh M, Okazaki H, Matsuzaki G, Suzuki N, Ishii A, Suko M, Okudaira H, Morita Y, Ito K: Increased IL-6 and IL-8 in bronchoalveolar lavage fluids (BALF) from patients with sarcoidosis: Correlation with clinical parameters. Clin Exp Immunol 1997;107:175-181.
4. Muller-Quernheim J: Sarcoidosis: Immunopathogenetic concepts and their clinical application. Eur Respir J 1998;12:716-738.
5. King J, Sinnott P, Swindell R, Pickering C, Thatcher N, Hasleton P: Transforming growth factor-β1 DNA polymorphisms in asbestos-related pulmonary fibrosis. Eur Respir J 2000;16(suppl 31):526s.
6. Robinson PC, Watters LC, King TE, Mason RJ: Idiopathic pulmonary fibrosis. Abnormalities in bronchoalveolar lavage fluid phospholipids. Am Rev Respir Dis 1988;137:585-591.
7. Gunter A, Schmidt R, Nix F, Yabut-Perez M, Guth C, Rosseau S, Siebert C, Grimminger F, Morr H, Velkovsky HG, Seeger W: Surfactant abnormalities in idiopathic pulmonary fibrosis, hypersensitivity pneumonitis and sarcoidosis. Eur Respir J 1999;14:565-573.
8. Low RB, Davis GS, Bell D, Giancola MS, Vacek PM: Lipids in bronchoalveolar lavage fluid from patients with sarcoidosis. Thorax 1987;42:926-932.
9. Baughman RP, Rennard SI: Bronchoalveolar lavage: General approaches to correct for variability of dilution and lung permeability. Eur Respir J 1999;9:28-31.
10. Mason RJ, Nellenbogen J, Clements JA: Isolation of desaturated phosphatidylcholine with osmium tetroxide. J Lipid Res 1976;17:281-284.
11. Ziegenhagen MW, Benner UK, Zissel G, Zabel P, Schlaak M, Muller-Quernheim J: Sarcoidosis: TNF-α release from alveolar macrophages and serum level of sIL-2R are prognostic markers: Am J Respir Crit Care Med 1997;156:1586-1592.
12. Sahashi K, Yasutaka I, Katsutoshi T, Toshihide S, Masahiko Y, Munehiko M: Significance of interleukin 6 in patients with sarcoidosis. Chest 1994;106:156-160.
13. Zissel G, Homolka J, Schlaak J, Schlaak M, Muller-Quernheim J: Anti-inflammatory cytokine release by alveolar macrophages in pulmonary sarcoidosis. Am J Respir Crit Care Med 1996;154:713-719.
14. Xing Z, Gauldie J, Cox G, Baumann H, Jordana M, Lei X, Achong MK: IL-6 is an anti-inflammatory cytokine required for controlling local or systemic acute inflammatory responses. J Clin Invest 1998;101:311-320.